Sort
85,873 grants matching “alzheimers”
Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease
$2,287,199Lisa L Barnes · Rush University Medical Center · R01 · FY2024 · AG
ARMADA: Advancing Reliable Measurement in Alzheimer's Disease and cognitive Aging
$2,286,972Richard Gershon · Northwestern University At Chicago · U2C · FY2019 · AG
Alzheimer's Disease Research Center
$2,286,967Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P50 · FY2016 · AG
VCID Biomarkers Coordinating Center
$2,286,910Steven M Greenberg · Massachusetts General Hospital · U24 · FY2025 · NS
Urban Air Pollution and Alzheimer's Disease: Risk, Heterogeneity, and Mechanisms
$2,286,579Caleb E Finch · University Of Southern California · P01 · FY2019 · AG
MOLECULAR PATHOGENESIS OF AGE-DEPENDENT CNS DEGENERATION
$2,286,570University Of California San Francisco · P01 · FY2000 · AG
Identification of Mild Cognitive Impairment using Machine Learning from Language and Behavior Markers
$2,286,356Jiayu Zhou · Michigan State University · RF1 · FY2021 · AG
Genomic and Metabolomic Data Integration in a Longitudinal Cohort at Risk for Alzheimer's Disease
$2,285,690Corinne D. Engelman · University Of Wisconsin-Madison · RF1 · FY2022 · AG
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology
$2,285,363Andrew J Saykin · Indiana University Indianapolis · U01 · FY2024 · AG
Bio-RaPID: Biomarkers and Rates of Progression In Dementia.
$2,285,244Gregory Scott Day · Mayo Clinic Jacksonville · R01 · FY2025 · AG
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-alpha1 in Neural and Cognitive Functions
$2,285,237Y. Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
The role of ABI3 in Alzheimers disease
$2,284,811Jungsu Kim · Indiana University Indianapolis · RF1 · FY2021 · AG
AGING BRAIN: VASCULATURE, ISCHEMIA, AND BEHAVIOR
$2,284,811Helena Chang Chui · University Of Southern California · P01 · FY2007 · AG
MOLECULAR PATHOGENESIS OF AGE-DEPENDENT CNS DEGENERATION
$2,284,764University Of California San Francisco · P01 · FY2001 · AG
ApoE, lipid and immune mechanisms of human neurons and glia
$2,284,296Ole Isacson · Mclean Hospital · RF1 · FY2023 · AG
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,284,142Michael S Rafii · University Of Southern California · R33 · FY2024 · AG
Examining the Persistence of Neurocognitive Benefits of Exercise
$2,284,063Kirk I Erickson · Adventhealth Orlando · R01 · FY2025 · AG
Molecular Center of Health and Disease
$2,283,750Michael R Garrett · University Of Mississippi Med Ctr · P20 · FY2023 · GM
Integrated Care Plans and Health Care Quality, Outcomes, and Equity for Medicare-Medicaid Dual Eligible Beneficiaries with Multimorbidity, Frailty, or Dementia
$2,283,522Jose Francisco Figueroa · Harvard University D/B/A Harvard School Of Public Health · RF1 · FY2024 · AG
TBI-ADRD Modeling with a Team Science Approach (TBI-ADRD Team Science)
$2,283,334Kevin Ka Wang Wang · Morehouse School Of Medicine · RF1 · FY2024 · NS
Functional Genomics and Bioinformatics Data management Core
$2,283,030Seyed Ali Mortazavi · University Of California-Irvine · U54 · FY2022 · AG
Molecular Center of Health and Disease
$2,282,949Michael R Garrett · University Of Mississippi Med Ctr · P20 · FY2024 · GM
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
$2,282,554Richard Mayeux · Columbia University Health Sciences · R01 · FY2022 · AG
p53, Aging, and Cancer
$2,282,517Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Investigating and targeting apolipoprotein E4 in Down syndrome-associated Alzheimer's disease
$2,282,487Noah Ray Johnson · University Of Colorado Denver · RF1 · FY2023 · AG